GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
LLY•Year-to-date performance
YTD, stock up 216.3%, Hang Seng Biotech Index .HSBIO up 11.2%.
Details of the collaboration
GenScript shares closed 14.3% higher on Thursday in their best day since August 7, after co announced collaboration with Lilly TuneLab, the AI/machine learning-based drug discovery collaboration platform of Eli Lilly.
GenScript will provide wet lab services to TuneLab member companies to generate experimental data and translate AI generated predictions into biological evidence.
GenScript shares extend rally after Eli Lilly collaboration
Shares of GenScript Biotech Corp 1548.HK jump 8.2% to HK$40.28, their highest level since December 2021.
The stock extends a rally from the previous session after announcement of collaboration with Eli Lilly and Company LLY.N.
The stock is the third-biggest pct gainer in the Hang Seng Biotech Index .HSBIO, which climbs 1.8%.
